We are live on ! Find out more
CFB

Cullen/Frost Bankers Portfolio holdings

AUM $10.1B
1-Year Est. Return 29.18%
This Fund
S&P 500
This Quarter Est. Return
+9.82%
1 Year Est. Return
+29.18%
3 Year Est. Return
+91.06%
5 Year Est. Return
+115.39%
10 Year Est. Return
+478.9%
AUM
$4.02B
AUM Growth
+$223M
Cap. Flow
-$95.4M
Cap. Flow %
-2.38%
Top 10 Hldgs %
27.72%
Holding
1,328
New
200
Increased
297
Reduced
377
Closed
136

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$17.9M
2
SFNC icon
Simmons First National
SFNC
+$13.6M
3
AMAT icon
Applied Materials
AMAT
+$13.5M
4
XLNX
Xilinx Inc
XLNX
+$11.9M
5
AAPL icon
Apple
AAPL
+$8.08M

Sector Composition

Rank Sector Weight
1 Technology 21.14%
2 Healthcare 12.66%
3 Financials 12.61%
4 Consumer Discretionary 12.09%
5 Communication Services 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOC icon
151
Healthpeak Properties
DOC
$14.2B
$5.22M 0.13%
192,250
+19,788
+11% +$542K
TRV icon
152
Travelers Companies
TRV
$77.2B
$5.18M 0.13%
47,867
+4,231
+10% +$485K
BDX icon
153
Becton Dickinson
BDX
$50B
$5.12M 0.13%
22,538
-5,238
-19% -$1.29M
AEP icon
154
American Electric Power
AEP
$67.9B
$5.11M 0.13%
62,494
+2,840
+5% +$234K
SYY icon
155
Sysco
SYY
$40.5B
$5.07M 0.13%
81,483
+24,543
+43% +$1.43M
WPC icon
156
W.P. Carey
WPC
$16.1B
$5M 0.12%
78,292
+5,335
+7% +$359K
IJJ icon
157
iShares S&P Mid-Cap 400 Value ETF
IJJ
$9.03B
$4.92M 0.12%
73,012
-4,728
-6% -$327K
MDLZ icon
158
Mondelez International
MDLZ
$79.4B
$4.9M 0.12%
85,311
-5,941
-7% -$331K
USB icon
159
US Bancorp
USB
$101B
$4.83M 0.12%
134,536
+11,780
+10% +$431K
LHX icon
160
L3Harris
LHX
$54.1B
$4.67M 0.12%
27,485
+1,645
+6% +$289K
BLK icon
161
Blackrock
BLK
$180B
$4.59M 0.11%
8,152
-530
-6% -$302K
IVW icon
162
iShares S&P 500 Growth ETF
IVW
$77.3B
$4.53M 0.11%
78,320
-7,656
-9% -$433K
VBTX
163
DELISTED
Veritex Holdings
VBTX
$4.45M 0.11%
261,490
OMC icon
164
Omnicom Group
OMC
$23.5B
$4.43M 0.11%
89,355
+4,374
+5% +$234K
NVO
165
Novo Nordisk
NVO
$203B
$4.3M 0.11%
123,848
+6,714
+6% +$224K
CBOE icon
166
Cboe Global Markets
CBOE
$30.4B
$4.2M 0.1%
47,892
-2,486
-5% -$224K
BR icon
167
Broadridge
BR
$19.3B
$4.19M 0.1%
31,767
-4,318
-12% -$577K
CE icon
168
Celanese
CE
$4.75B
$4.19M 0.1%
38,958
+2,026
+5% +$202K
VV icon
169
Vanguard Morningstar Large-Cap ETF
VV
$54.5B
$4.11M 0.1%
26,260
-23,564
-47% -$3.63M
EXPE icon
170
Expedia Group
EXPE
$39.1B
$4.07M 0.1%
44,436
+2,879
+7% +$259K
TMO icon
171
Thermo Fisher Scientific
TMO
$223B
$4.07M 0.1%
9,225
-715
-7% -$295K
ADI icon
172
Analog Devices
ADI
$187B
$4.05M 0.1%
34,717
-1,249
-3% -$146K
CAH icon
173
Cardinal Health
CAH
$54.5B
$4.02M 0.1%
85,601
+5,439
+7% +$279K
CL icon
174
Colgate-Palmolive
CL
$73.6B
$3.92M 0.1%
50,793
-7,640
-13% -$583K
TMUS icon
175
T-Mobile US
TMUS
$190B
$3.89M 0.1%
34,010
+32,112
+1,692% +$3.56M

Similar funds

Cullen/Frost Bankers's Q3 2020 Portfolio in Review

As of Q3 2020, Cullen/Frost Bankers held 1,328 positions worth $4.02B, up 5.9% from $3.79B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Cullen/Frost Bankers's Q3 2020 filing shows 200 new, 297 increased, 377 reduced and 136 closed positions. Its largest new stake was INPHI CORPORATION: 96,001 shares worth $10.8M. The largest sale was AbbVie, an estimated $17.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Cullen/Frost Bankers's largest Q3 2020 buy was INPHI CORPORATION: 96,001 shares worth $10.8M.
  • Cullen/Frost Bankers added most to Qualcomm in Q3 2020, an estimated $13.8M increase.
  • Cullen/Frost Bankers's biggest Q3 2020 reduction was AbbVie, cutting an estimated $17.9M.
  • Cullen/Frost Bankers fully exited Simmons First National in Q3 2020, selling an estimated $13.6M.
  • Cullen/Frost Bankers's ten largest holdings make up 28% of its $4.02B portfolio in Q3 2020.
  • Cullen/Frost Bankers opened 200 new positions and closed 136 in Q3 2020.
  • Cullen/Frost Bankers's portfolio value rose 5.9% quarter-over-quarter to $4.02B.

Based on Cullen/Frost Bankers's 13F filing for Q3 2020, filed 5 Nov 2020.